Backed by extensive experience in venture capital, the fund manager has executed over 30 deals primarily in the technology and healthcare sectors across North America and Europe. Their strategic operator-first approach has led to several notable exits, including a successful IPO in the biotech field. Actively engaging in early-stage investments, they leverage a data-driven methodology to identify emerging trends and high-potential startups. This combination of regional focus and thematic investment style positions the manager as a key player in driving innovation and growth within the industry.